logo
I've lost 21st on Mounjaro after spending £600 on takeaways a month – but I was left with a frustrating side effect

I've lost 21st on Mounjaro after spending £600 on takeaways a month – but I was left with a frustrating side effect

The Sun2 days ago
JOANNA Higgenbottom spent almost £600 ($800) each month on takeaways, before Mounjaro helped her shed 21 stone.
The 60-year-old had struggled with her weight, with her first memory being her aunt calling her "fat Jodie".
5
5
At her heaviest, the medicare affiliate, from Columbia, North Carolina, US, was 490lbs (35 stone) and was a size US 32 (UK 36) after years of daily takeout.
And after trying "every diet in the book" she went to her doctor, who recommended weight loss jab GLP-1.
Joanna said she noticed a change in two weeks, and now weighs 164 lbs and fits into a size 12 (UK 16).
However, she was initally left with lots of excess skin, that she would fold into her clothes to keep out of the way.
Joanna credits the injections alongside walking 21 miles a week - including 10k steps a day - and lifting weights twice a week.
She said: "I would spend lots of money on fast food.
"Then DoorDash became an option, and I didn't even have to leave the house.
DoorDash is a US-based food delivery platform, similar to Deliveroo or Uber Eats in the UK, that lets you order meals through its app or website.
"I was able to stay at home and save the embarrassment of being looked at by people due to my size," she explained.
"I would order from DoorDash daily and spend around $600 to $800 (£470–£625) a month."
Joanna said one of her earliest memories growing up was her aunt calling her "fat Jodie."
She said before her mother, Mary Jenkins, passed away at age 88, she had promised to lose weight.
Joanna said: "I became a caretaker for my mother; she struggled with weight later in life, and it bothered her that I was going through the same thing.
"It got to the point where I could not walk through the grocery store without having to stop and catch my breath.
"I made the promise to my mom before she passed that I would get my weight under control."
5
In June 2022, Joanna decided to go on a keto diet - a very low- carbohydrate, high-fat diet - and lost 250 lbs (17 stone and 11lbs).
But sadly Joanna started to gain weight again and went up to 386.8 lbs (27 stone and 6lbs).
A year later, on June 6, 2023, Joanna, a type 2 diabetic, was put on GLP-1 by her doctor.
Joanna said: "It was a last-ditch effort. I had tried everything.
"Nothing would work for me. I tried Weight Watchers, I tried Overeaters Anonymous, and nothing would work for me.
"I had always come back dependent on food."
Now weighing 164 lbs (11 stone 7lbs), Joanna has lost 21st or 294 lbs.
She has deleted the DoorDash apps and eats high-protein vegetarian meals - including tofu, cottage cheese, and eggs.
'I feel cute'
Joanna has slimmed down to a size 12 and says she now feels comfortable going clothes shopping.
She said: "I am so much more confident now. My daughter said this is the first time in her life that she has seen me so confident.
"For the first time in my life, I feel cute and confident - I have never felt this way.
"Before, I would hate going clothes shopping and buying clothes that would cover me up the most.
"Now I wake up ready to go. I am happy and ready to go."
Joanna said she is happy with her weight now, and that she doesn't want to become "obsessed" with losing weight.
As well as taking four GLP-1 injections a month - costing $500 (£371.48) - Joanna will work out most days.
Joanna said: "At first, I started going on 10-minute walks around the house.
"Now, on the weekend, I will walk around six miles, and I will try to walk two to three miles a day.
"I try to lift weights three times a week, too.
"I am happy with where I am, I don't want to get bigger, and I don't want to get to the point where I am obsessed with losing weight."
'I had to tuck my skin into my underwear'
In July 2025, Joanna underwent skin removal surgery to remove 8 1/2lbs of excess skin.
She said this has allowed her to become much more confident in herself.
"My skin hang was so severe it hung so low, I had to tuck my skin into my underwear to even be able to go walking.
"It was so frustrating to lose all that weight and have a constant reminder of how big I used to be.
"Now I have the confidence to try new things, I went to an aerial workout class, and I would never have done that before now."
Are you eligible for weight loss jabs on the NHS?
By Sam Blanchard, Health Correspondent
THEY are arguably the biggest medical breakthrough of recent times.
And now, so-called ' fat jabs ' are available to many more Brits on the NHS.
In what marks the dawn of a new era, GPs have begun prescribing the weight loss jab Mounjaro in the first anti- obesity rollout of its kind.
More than three million people are thought to be eligible for tirzepatide - the active drug in Mounjaro - the strongest jab on the market.
Health chiefs hope it will turn the tide on England's obesity crisis which has seen rates double since the 1990s.
Injections including Ozempic and Wegovy have previously only been available for type 2 diabetes or through specialist slimming clinics.
Family doctors will now be encouraged to prescribe them in a bid to get more people on the meds.
Experts hope widespread use will slash work sick days and boost the economy, while reducing rates of cancer, heart disease and dementia.
But demand for the drugs is already huge and NHS clinics cannot dish them out fast enough.
Who is eligible in the new rollout?
The new rollout allows GPs to prescribe tirzepatide for weight loss, starting with those patients whose weight places them at greatest health risk.
Top of the list will be those with a body mass index (BMI) of 40 or higher (or 37.5 if from a minority ethnic background) and four weight-related health conditions.
A BMI of 40 is roughly equal to weighing 16st (102kg) for an average height 5'3' woman, or 19st 6lbs (123kg) for an average 5'9' man.
Weight-related conditions include high cholesterol, high blood pressure, prediabetes, type 2 diabetes, obstructive sleep apnoea and heart disease.
Patients will likely be expected to have tried diet and exercise first before being offered a jab.
Many are likely to miss out, as some 13.5million adults in England are obese but only 3.4million are estimated to be eligible in the rollout.
Professor Kamila Hawthorne, chair of the Royal College of GPs, said: 'Currently only patients who meet certain criteria - those who could benefit most - are eligible to be prescribed weight loss drugs on the NHS, and GPs will also need to follow local guidelines when prescribing.
'If your practice advises you that they won't be able to provide weight loss medication, these will likely be the reasons why.
'We appreciate the idea of weight loss medication is an attractive prospect to many patients - and they do have a lot of potential benefits for patients and may be a valuable tool as we try to tackle obesity at a national level – but it's important these medications aren't seen as a silver bullet.
'Weight loss drugs do not come without risk, they can cause side effects which range in seriousness, and they won't be suitable for everyone.
'It's important we don't lose sight of the role lifestyle factors play in achieving a healthy weight.
'The roll out of weight loss medications as a treatment for obesity must not come at the expense of other weight loss services.'
If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services.
Known as tier 2 and tier 3 weight management services, they may prescribe the jabs after other weight loss attempts.
Many people are expected to find it easier to go private, with the injections widely available from high street pharmacies like Boots, Superdrug, and even Asda.
There are also numerous online pharmacies offering the drugs.
Buying the drugs online might seem like the faster fix – but buyer beware.
Slimming success stories are everywhere but so, too, are tales of horror.
Many patients have been duped by dodgy sellers, suffered severe side effects or even died after taking jabs they bought online.
Bargain prices, easy tick-box applications, or prescriptions with no follow-up, should all be red flags to online shoppers.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Woman who refused to eat for the first decade of her life choked on her own vomit, inquest hears
Woman who refused to eat for the first decade of her life choked on her own vomit, inquest hears

Daily Mail​

timean hour ago

  • Daily Mail​

Woman who refused to eat for the first decade of her life choked on her own vomit, inquest hears

A woman who refused to eat for the first decade of her life choked on her own vomit, an inquest heard. Tia-Mae McCarthy, 21, baffled doctors as a child with her refusal to eat, surviving on tube feeds until she was a teenager. Her case drew national attention and was the subject of a 2006 TV documentary, The Girl Who Never Ate, which followed her mother Sue's search for answers. The 21-year-old from Fordingbridge, Hampshire, was born 12 weeks premature and weighing just 2lb 3oz, spent much of her first year in hospital. She was diagnosed with oesophageal atresia, a rare condition where the foodpipe does not connect to the stomach. She underwent surgery at three months old to move her stomach into her chest. Although the surgery meant she was physically capable of eating, she refused all food and had to be fed through a tube while she slept. Her mother, Susan McCarthy, believed it was psychological, linked to repeated medical trauma in her early months when she stopped breathing and had to be resuscitated. Then, at the age of ten, she suddenly accepted a spoonful of yoghurt – the start of a remarkable transformation that saw her ditch her feeding tube by the end of 2012. By 15, she was eating a full diet, from mac and cheese to salmon and venison. But she was found unresponsive in bed at her family home on April 28 this year. An inquest in Bournemouth heard the oesophageal surgery she had as a baby left her at lifelong risk of aspiration, food or liquid entering the airway, which could 'happen at any time'. The inquest heard she had a 'rattly' cough for about a week before her death. In a statement read to the court, her mother said her daughter had developed a cough about a week before her death, which was not unusual for her. She added: 'We were planning to go on holiday. 'On Sunday, I noticed her cough was a bit rattly. I was with Tia all day on Sunday - we went out for a coffee. 'She was really bright and cheery and enjoyed her time at the riding club. 'I messaged Jason (Tia's stepfather) and asked if Tia was OK, he told me she was still croaky. 'I messaged Tia to see if she was OK, and she replied to say yes, and this was the last time I had communication with her.' Her step-father, Jason Allman, had propped her up with extra pillows the night before she died to help her cough and breathing. The mother said she went upstairs the following day and discovered her daughter unresponsive in bed with the covers off, and realised she had died. Her step-father, Jason Allman, had propped her up with extra pillows the night before she died to help her cough and breathing. A post-mortem found vomit in the main and peripheral airways, with stomach fluid and remnants of the mac and cheese she had for dinner the night before. While Tia did have other disabilities, there was no medical reason after the surgery why she could not eat food and her case baffled the experts. Tia was featured in the documentary in which her mother took her to a specialist clinic in Austria. The controversial research programme even included periods of controlled starvation. Tia had other learning difficulties, which meant she could not live independently, and she still lived at home with her mother. She enjoyed riding and attended an adult day centre. In a police statement read to the court, officers said there were no suspicious circumstances and praised the care Ms McCarthy received from her family, saying: 'We attend a lot of vulnerable people - Tia was incredibly well supported and cared for by her mother and stepfather.' Recording his conclusion, Mr Allen said: 'I am satisfied on the basis of the circumstances that the cause of death is gastro-oesophageal aspiration. 'Tia-Mae McCarthy had a past medical condition which left her at increased risk of aspiration. She died as a consequence of a recognised risk factor of a previous surgical procedure.'

How booming ‘fat jab' black market is STILL rife after celeb stylist sells meds to Sun reporter for £280 via Instagram
How booming ‘fat jab' black market is STILL rife after celeb stylist sells meds to Sun reporter for £280 via Instagram

The Sun

timean hour ago

  • The Sun

How booming ‘fat jab' black market is STILL rife after celeb stylist sells meds to Sun reporter for £280 via Instagram

WEIGHT loss drugs are still being brazenly flogged on the black market by a celebrity hairdresser who gave The Sun a Mounjaro jab with NO consultation, Sun Club can reveal. The news has led Mounjaro manufacturer Lilly to beg those taking weight loss drugs to only buy from a licensed healthcare professional and warn that "dangerous" black-market products are often made in "unsanitary conditions". 9 9 9 As part of a Sun probe, we obtained self-injectable Mounjaro, dubbed the King Kong of fat jabs, for £280 after responding to an Instagram post by celeb stylist Ozzy Tudo, who is known for working with Katie Price and telly personality Jessica Alves. Our reporter was sold potentially deadly prescription weight loss drugs by Tudo, despite having a normal BMI and telling him she wanted to shed at least one stone in just TWO WEEKS before going "on holiday". The investigation exposed the ease of obtaining the fashionable diet drugs on the booming black market and, despite being confronted about the illegal sale on hidden cameras, Tudo has now started openly selling them again. Less than 24 hours ago, he posted an image of a slim model in white underwear with bottles of Mounjaro underneath and wrote the caption: "Available at great price #mounjaro." He also then posted an image of a Mounjaro injection pen to his 72k followers with the words: "#mounjaro. Very effective." When we asked Tudo about him continuing to sell Mounjaro over Instagram, he said: 'Why don't u go after the pharmacies which sells hundreds or thousands of pens without prescription [sic]? "It's no me do does wrong , it's these big companies, pharmacies and suppliers who sells to everyone who pays pharmacies accept fake prescriptions or without prescription [sic]." Asked to provide evidence that he was a qualified prescriber, Tudo refused to respond. Weight loss drugs can only be lawfully supplied when prescribed for someone by an appropriate practitioner – such as a doctor, a nurse or a pharmacist-independent prescriber - after a detailed health assessment. Mounjaro - which has been linked to 33 deaths in the UK - is approved for adults who are classed as "obese", so with a BMI of 30 or more, or those with a BMI of 27 or more who also have weight-related health conditions. I went on fat jabs but the hair loss was unbelievable so I quit - I'd rather be chubby with hair than skinny and bald However, earlier this year our reporter - who has a BMI of 21 - contacted Tudo through a mobile number on his Instagram account, which he uses to advertise Mounjaro and Ozempic. She told him she weighed nine-and-a-half stones, a size small dress size, and wanted to shed at least one stone before going on a holiday. She was not asked her height or her BMI. She was also not asked for her name or address. Tudo, 47, advised that a dose of 5mg 'is enough' and said to travel to his studio near King's Cross Station in London, where he would supply the drug. Once at the address, a woman, who did not speak English, led us up a staircase and handed over a brown paper bag containing the pen - which holds four injections of the drug, to be taken once a week for a month. With no consultation or explanation of how the prescription drug works, our reporter messaged Tudo saying: 'I don't know how to take it.' He replied: "Send u a video. It's so easy." The hairdresser then sent a YouTube tutorial video on how to self-inject. Asked if it would have any side effects, he replied: "It depends on each person, usually no." When we later confronted Tudo about the illegal sale, which was filmed using concealed cameras, he said: 'I don't even have Mounjaro here.' Pressed on how he prescribed the drug, which has been linked to 'deaths' without the necessary qualifications or even asking our undercover reporter for a name, he said: 'Deaths? No. Just a few overdoses.' Harley Street doctor Sophie Shotter, who has been practising for 16 years, said it was "terrifying' and a "risk to public health" that The Sun had obtained the drug without any medical consultation. Everything you need to know about fat jabs Weight loss jabs are a hot media topic at the moment, with hundreds of success stories from people who shed the pounds. In March 2023, the NHS announced it would make Wegovy, a drug made by Danish firm Novo Nordisk, available on prescription to thousands of obese Brits. It contains the drug semaglutide, which is said to have helped reality star Kim Kardashian and Twitter boss Elon Musk lose weight. Wegovy, which helped a third of people reduce their weight by 20 per cent in trials, is now available from pharmacies like Boots. How do they work? The jabs work by suppressing your appetite, making you eat less and therefore lose weight. To do this, semaglutide mimics the role of a natural hormone, called GLP-1. GLP-1 is part of the signalling pathway that tells your body you have eaten, and prepares it to use the energy that comes from your food. London GP and founder of Dr Zoe Watson, said: 'Your body naturally produces an appetite regulating hormone called glucagon-like peptide-1. 'These jabs work by regulating your appetite, which can lead to eating fewer calories and losing weight.' Aren't they diabetes drugs? Semaglutide, the active drug in Wegovy, was originally sold under the name Ozempic specifically for diabetes patients. But people started noticing it helped suppress their appetites, stopping them eating as much and helping them shed the pounds. Novo Nordisk then developed Wegovy, which contains the same chemical but at higher doses specifically to aid weight loss. Wegovy is not prescribed for diabetes patients. Can I get them? Wegovy is offered on prescription to obese adults given specialist weight loss treatment. The NHS currently also offers a similar drug called Saxenda, or liraglutide. Both are only available throught specialist weight management services, which means you have to be referred to clinics led by experts. GPs can't prescribe them on their own, Dr Watson said. The jabs have to be taken as part of an overall programme to help with lifestyle changes and psychological support to get the best effect from the medication prescribed. Are there any risks? Like all medicines, the jabs do not come without side effects. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. What other options are there? Mounjaro (brand name for tirzepatide) also came onto the market in early 2024. Like Wegovy, tirzepatide stems from a drug originally designed to treat diabetes. The weekly injection helped overweight people drop more than two stone in 18 months. It is available with to order with a prescription online from pharmacies including Superdrug and LloydsPharmacy Online Doctor. It works in a similar way to Wegovy and Saxenda, but is more effective. Dr Mitra Dutt from LloydsPharmacy says: 'Based on clinical trials, 96 per cent of people were able to lose more than five per cent of their body fat using Mounjaro. In similar trials, 84 per cent of people lost more than five per cent of their body weight on Wegovy, and 60 per cent on Saxenda. 'Mounjaro works by activating two hormonal receptors (GIP and GLP-1), which enhance insulin production, improve insulin sensitivity, and work to decrease food intake." After examining the pen at her Harley Street practice, Dr Shotter said: "This is a controlled, prescription-only drug. "This is a UK-approved pen, so this has not been smuggled into the country. "It is a huge concern, because, how has it appeared on the black market in the first place? "If you [our reporter] came into my surgery asking to go on a weight loss drug, immediately the answer would be, 'No.' "If you lost one to two stones, you could drop into a low BMI category. "This is not what the drug is intended for and it is, quite frankly, terrifying that you've been able to buy it. And not just that, it is the fact, you've been placed on a higher dose. "If a patient came to me who did qualify because of their weight, then I would have a thorough consultation with them. 'I would possibly run blood tests to ensure it is as safe as possible and to make sure there are no underlying liver or pancreatic problems. "This man has not even asked you your name, so how is the drug being prescribed? It is impossible that this is legitimate. "It is a genuine risk to public health and especially dangerous to those with eating disorders. 'These drugs carry risks to your health and your mental health, especially to those who suffer from eating disorders.' 9 9 9 9 The rise in the 'dangerous' black market availability of weight loss injections is being increasingly seen by eating disorder charities in the UK. After being informed about The Sun's investigation, Tom Quinn, Beat's Director of External Affairs said: "We're incredibly concerned that it's so easy to access weight loss injections on the black market. "Medications which cause weight loss can be very attractive to people with eating disorders, and can contribute to these dangerous mental illnesses getting worse. "They pose severe health risks, especially if they are easily accessible without prescriptions. "Weight loss injections are very serious medications with severe side effects such as vomiting and nausea, which can contribute to an eating disorder developing, or make it worse. "We also have concerns about what happens after somebody stops taking these drugs. If somebody gains weight after their prescription finishes, this may trigger feelings of guilt and shame, which could increase the chances of an eating disorder developing. "More action needs to be taken to prevent these drugs being so easily accessible. 'And it's vital that there is more education so that people are aware of how dangerous it is to abuse medication in order to lose weight. "For those with binge eating disorder, losing weight won't help a person recover from an eating disorder. 'While it may bring their BMI down in isolation, it will do nothing to address the root cause or symptoms of the eating disorder – and could make things worse. "Doctors and pharmacies must make the general public aware of these dangers, and ensure that prescriptions are only possible after stringent health checks." BLACK MARKET Medicines bought on the black market that have not been through rigorous safety testing bring additional risks. The market leaders Mounjaro, which contains tirzepatide, and Ozempic, which contains semaglutide, are administered via injection of pre-filled pens. They work by mimicking the hormone glucagon-like peptide-1, which is released after eating, and suppresses a patient's appetite. The National Institute of Health and Care Excellence (Nice) recommends semaglutide for adults who have at least one weight-related comorbidity and a body mass index (BMI) score of at least 35, or a BMI of at least 30 and meet criteria for referral to a specialist weight management service. A Lily spokesperson said: "Patients should only use Mounjaro (tirzepatide) when prescribed by a licensed healthcare professional and prescriptions should be fulfilled and supplied only by registered pharmacies and providers. Any tirzepatide offered without a prescription or for purchase on social media or black market is unlawful. These products are either fake or being 'resold' by an individual who obtained them through illicit means. Both practices put patients at risk. "Counterfeit, fake, and other unsafe products that are sold in a manner that falsely represents their authenticity, origin, or effectiveness are dangerous. These black-market products are often made in unsanitary conditions, which is especially dangerous for sterile injectables, like tirzepatide. "They may contain the wrong ingredients, contain too much, too little, or no active ingredient at all, or contain other harmful ingredients. No one should ever risk putting them into their bodies. "Lilly has taken steps to help address the risks posed by the proliferation of counterfeit, fake, and unsafe products across the world, including working with regulators and law enforcement, and identifying and removing fraudulent or unsafe content online and on social media — and we will continue to pursue all available avenues to combat fake and black-market medicines. "But our efforts alone are not enough. We applaud the MHRA's warnings on the risks of unsafe fake weight loss pens and the risks of buying medicines online without a prescription, and we welcome their continued partnership in the fight against counterfeit and illegal medicines. "We call upon regulators and law enforcement across the globe to take action against those who threaten the health and wellbeing of patients by selling fake or unsafe medicines." 9 9

Trump's efforts to defund Planned Parenthood threatens US healthcare system, study suggests
Trump's efforts to defund Planned Parenthood threatens US healthcare system, study suggests

The Guardian

time2 hours ago

  • The Guardian

Trump's efforts to defund Planned Parenthood threatens US healthcare system, study suggests

Planned Parenthood clinics treated people who rely on Medicaid at more than 1.5m visits in 2024, new research published Wednesday shows. But the reproductive health giant's ability to treat those patients is now in jeopardy due to Republicans' efforts to 'defund' Planned Parenthood by kicking it out of Medicaid. Donald Trump's tax and spending package, passed in July, bans Planned Parenthood from receiving reimbursements from Medicaid, the US government's insurance program for low-income people. After Planned Parenthood sued over the ban, a judge temporarily stopped it from taking effect. If the ban moves forward, experts warn that it could cripple the entirety of the US healthcare social safety net. 'Planned Parenthood has filled a very important role in the reproductive healthcare safety net for people living on low incomes,' said Kari White, executive and scientific director at Resound Research for Reproductive Health. White was the lead author on the research paper released Wednesday. 'Other providers have counted on them to do so. They just don't have the capacity to step in and fill the place that Planned Parenthood has had in the safety net.' In particular, White said, people will probably struggle to access contraception. After Texas started to ice Planned Parenthood out of its Medicaid program more than a decade ago, placements of contraceptive implants and IUDs – two of the most effective methods of birth control – fell by more than a third in counties that had a Planned Parenthood clinic. That indicated that those who had used Medicaid to obtain contraception at Planned Parenthood were no longer doing so. Provision of injectable contraceptives also fell; among people who used it, births covered by Medicaid rose by almost a third. Republicans have long sought to defund Planned Parenthood over the organization's commitment to providing abortions. But Planned Parenthood does not rely on Medicaid to fund its abortion provision as it is already illegal to use federal dollars, including Medicaid, to pay for the vast majority of abortions. The 1.5m visits documented in Wednesday's research paper, which was published in the medical journal Jama, only include visits for reasons other than abortion. More than 80 million people in the US use Medicaid, and 11% of female Medicaid beneficiaries who are between the ages of 15 and 49 and who receive family-planning services go to Planned Parenthood, according to an analysis by the non-profit KFF, which tracks healthcare policy. But defunding Planned Parenthood will probably hit blue states hardest, since they are home to larger numbers of Medicaid beneficiaries. About 50% of the people who visit Planned Parenthood of Orange and San Bernardino Counties, which operates clinics in California, use Medicaid in some way, experts told the Guardian. If the defunding moves forward, the affiliate would lose roughly $50m, or half of its budget. It already went without Medicaid reimbursements for about five weeks earlier this year. 'It was a really stressful time for my staff. They have fees and bills to pay. And some of them probably were wondering if they would still have a job,' recalled Dr Janet Jacobson, the affiliate's medical director and vice-president of clinical services. 'It's hard not to take federal legislation that basically comes out and names you and threatens you and tries to defund you personally.' Jacobson is particularly worried about the future of a program at Planned Parenthood of Orange and San Bernardino Counties that screens about 100,000 patients annually for sexually transmitted infections. Between July 2024 and June 2025, the affiliate uncovered more than 1,500 positive tests for syphilis, as well as almost 400 cases of trichomoniasis in pregnant women. Both STIs – which often do not have symptoms in their early stages – can have devastating consequences for pregnant women and their babies, such as preterm birth and birth defects. 'They haven't been able to ban abortion outright, so they're trying to take away the money for services like cancer screening, STI testing, birth control, and essentially trying to shut us down that way so that we can't provide abortion,' said Nichole Ramirez, senior vice-president of communication and donor relations at Planned Parenthood of Orange and San Bernardino Counties. 'They're taking away this vital care from mostly underserved communities. They're willing to have an increase in STIs, have a potential increase in cancer rates so that they can try to get rid of abortion.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store